Literature DB >> 32671220

SWEET SYNDROME AND HASHIMOTO THYROIDITIS: A CASE REPORT AND REVIEW OF THE LITERATURE.

Jacob Goodwin, Samuel Ives, Hiba Hashmi.   

Abstract

OBJECTIVE: Sweet syndrome (SS) is characterized by an inflammatory rash that has been associated with a number of drugs and malignant, inflammatory, and infectious conditions. Rare accounts of Hashimoto thyroiditis (HT) presenting with SS exist in the literature. HT is usually identified after the onset of skin lesions and without signs of overt thyroid dysfunction, and the stage of thyroid disease stage at presentation is variable.
METHODS: A search of the PubMed database was performed using search criteria involving combinations of "Sweet syndrome" and "Hashimoto thyroiditis," "autoimmune thyroiditis," or "thyroiditis," and the search was filtered for clinical case reports. Five case reports were identified to describe the coexistence of Sweet syndrome and Hashimoto thyroiditis, and full-text versions of these reports were obtained and reviewed. Of note, cases involving subacute or other types of thyroiditis were excluded.
RESULTS: A 57-year-old man presented with painful eruptions on his hands; he was initially treated with antibiotics for presumed cellulitis without relief. Skin biopsy later confirmed SS and subsequent workup identified underlying HT with an elevated thyroid-stimulating hormone of 19.24 mU/L (normal, 0.30 to 4.30 mU/L) and positive thyroid peroxidase (TPO) antibody at 236.4 IU/mL.
CONCLUSION: Thyroid function tests should be universally evaluated in the workup of SS, and it may be appropriate to test for TPO antibodies even in the absence of objective thyroid dysfunction. Both SS and HT show immune diathesis, so further work should be undertaken to establish whether a common immunologic trigger exists.
Copyright © 2020 AACE.

Entities:  

Year:  2020        PMID: 32671220      PMCID: PMC7357608          DOI: 10.4158/ACCR-2019-0579

Source DB:  PubMed          Journal:  AACE Clin Case Rep        ISSN: 2376-0605


  7 in total

1.  Transient autoimmune thyroiditis associated with Sweet's syndrome.

Authors:  Renu Rattan; Abhishek Sharma; Vinay Shanker; Gita R Tegta; Ghanshyam K Verma
Journal:  Indian J Dermatol Venereol Leprol       Date:  2016 Jan-Feb       Impact factor: 2.545

2.  Sweet syndrome associated with Hashimoto thyroiditis.

Authors:  Sandra Medeiros; Raquel Santos; Victor Carneiro; Francisca Estrela
Journal:  Dermatol Online J       Date:  2008-09-15

Review 3.  Neutrophilic dermatoses: Pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis, and Behçet disease.

Authors:  Caroline A Nelson; Sasha Stephen; Hovik J Ashchyan; William D James; Robert G Micheletti; Misha Rosenbach
Journal:  J Am Acad Dermatol       Date:  2018-04-11       Impact factor: 11.527

4.  Autoimmune clustering: sweet syndrome, Hashimoto thyroiditis, and psoriasis.

Authors:  Mohammad Saeed; Grace E Brown; Abhishek Agarwal; Donna Pellowski; Jennifer Jacks; Hazel K Liverett; Keyur S Vyas
Journal:  J Clin Rheumatol       Date:  2011-03       Impact factor: 3.517

5.  Immunological changes of T helper cells in flow cytometer-sorted CD4+ T cells from patients with Hashimoto's thyroiditis.

Authors:  Yanying Guo; Jazyra Zynat; Shuqing Xing; Liang Xin; Suli Li; Nurongguli Mammat; Yuan Chen; Limin Zhao; Hongli Zhao; Xinling Wang
Journal:  Exp Ther Med       Date:  2018-02-01       Impact factor: 2.447

6.  Neutrophilic dermatosis of the face associated with aortitis syndrome and Hashimoto's thyroiditis.

Authors:  H Nakayama; S Shimao; T Hamamoto; C Munemura; A Nakai
Journal:  Acta Derm Venereol       Date:  1993-10       Impact factor: 4.437

Review 7.  Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis.

Authors:  Philip R Cohen
Journal:  Orphanet J Rare Dis       Date:  2007-07-26       Impact factor: 4.123

  7 in total
  1 in total

Review 1.  New Practical Aspects of Sweet Syndrome.

Authors:  Tejas P Joshi; Sarah K Friske; David A Hsiou; Madeleine Duvic
Journal:  Am J Clin Dermatol       Date:  2022-02-14       Impact factor: 7.403

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.